BioNexus Gene Lab (BGLC) said it is partnering with ML Tech to optimize its Ethereum-focused treasury strategy.
The company said it plans to leverage ML Tech's digital asset trading infrastructure to grow its Ethereum holdings. ML Tech is a wealth management platform for digital assets.
Shares of the company were up over 3% in recent trading.
Price: 0.36, Change: +0.01, Percent Change: +3.77
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。